2026

Regulatory milestones and corporate developments.

08

May

2026

HKRM Becomes Hong Kong’s First Department of Health-Recognised Allogeneic MSC PIC/S GMP Facility

In May 2026, Hong Kong Regen Medtech Limited became Hong Kong’s first Department of Health-recognised allogeneic mesenchymal stem cell (MSC) PIC/S GMP facility. The Drug Office’s public List of Licensed Pharmaceutical Manufacturers lists HKRM under Licence No. ML-179, with its registered manufacturing site at Hong Kong Science Park and licence valid until 03.05.2027.

Department of Health Drug OfficeView Drug Office Listing